APA (7th ed.) Citation

Traoré, A., Guindo, M. A., Konaté, D., Traoré, B., Diakité, S. A., Kanté, S., . . . Balam, S. (2022). Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Traoré, Abdouramane, et al. Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas. Frontiers Media S.A, 2022.

MLA (9th ed.) Citation

Traoré, Abdouramane, et al. Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas. Frontiers Media S.A, 2022.